Siobhan Stokes

Siobhan Stokes

Auto-generated profile, based on publicly available information

Siobhan Stokes

HSE National Drug Treatment Centre

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2015 in Eurosurveillance
Verified
Journal Article
Open access
CGCoralie Giese
Coralie Giese
DIDerval Igoe
Derval Igoe
ZGZorina Gibbons
Zorina Gibbons
CHCaroline Hurley
Caroline Hurley
SSSiobhan Stokes
Siobhan Stokes
OTon behalf of the outbreak control team
on behalf of the outbreak control team
In February 2015, an outbreak of recently acquired HIV infections among people who inject drugs (PWID) was identified in Dublin, following similar outbreaks in Greece and Romania in 2011. We compared drug and risk behaviours among 15 HIV cases and 39 controls. Injecting a synthetic cathinone, snow blow, was associated with recent HIV infection (AOR: 49; p = 0.003). Prevention and control efforts are underway among PWID in Dublin, but may also be needed elsewhere in Europe.

11 January 2013 in Journal of Analytical Toxicology
Verified
Journal Article
Open access
PDF file
POPaul O'byrne
Paul O'byrne
PKPierce V. Kavanagh
Pierce V. Kavanagh
SMSinead M. McNamara
Sinead M. McNamara
SSSiobhan M. Stokes
Siobhan M. Stokes
A rapid, reproducible and sensitive reversed phase liquid chromatography–mass spectrometry method was developed and validated for the identification and semi-quantitative confirmation of stimulants in urine. The method is capable of separating compounds such as cocaine and metabolites, amphetamines, substituted cathinones and other designer drugs, with a total run time of 11 min. The method was subsequently used to confirm the presence of these stimulants in the urine of patients attending the Drug Treatment Centre Board Ireland over the period in which legislation banning some named cathinones was introduced in Ireland. Substituted cathinones were the predominant drug of choice, outside of cocaine use. Mephedrone was the most widely detected cathinone in 2010, whereas 3,4-methylenedioxypyrrolidinobutyrophenone featured more prevalently in screenings in 2011. The appearance of adverse effects increases during multi-stimulant use related to synergistic pharmacological combinations, and this method has benefits in identifying multi-drug use between next generation designer drugs and commonly used stimulants.

29 January 2016
Verified
Journal Article
Closed access
SMS McNamara
S McNamara
SSS Stokes
S Stokes
RKR Kilduff
R Kilduff
ASA Shine
A Shine

2 March 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
GCGráinne Cousins
Gráinne Cousins
LDLouise Durand
Louise Durand
AOAoife O’kAne
Aoife O’kAne
JTJulie Tierney
Julie Tierney
RMRichard Maguire
Richard Maguire
EKEamon Keenan
Eamon Keenan
Introduction There is an increasing concern about the misuse of prescription drugs. Misuse refers to the intentional repurposing of prescribed drugs and/or the use of illicitly sourced prescription drugs, which may be counterfeit or contaminated. Drugs with the greatest potential for misuse are prescription opioids, gabapentinoids, benzodiazepines, Z-drugs and stimulants. Objective The aim of this study is to provide a comprehensive analysis of the supply, patterns of use and health burden associated with prescription drugs with potential for misuse (PDPM) in Ireland between 2010 and 2020. Three inter-related studies will be carried out. The first study will describe trends in supply of PDPM using law enforcement drug seizures data and national prescription records from national community and prison settings. The second study aims to estimate trends in the detection of PDPM across multiple early warning systems using national forensic toxicology data. The third study aims to quantify the health burden associated with PDPM nationally, using epidemiological indicators of drug-poisoning deaths, non-fatal intentional drug overdose presentations to hospitals and drug treatment demand. Methods and analysis A retrospective observational study design, with repeated cross-sectional analyses, using negative binomial regression models or, where appropriate, joinpoint regression. Ethics and dissemination The study has received approval from the RCSI Ethics Committee (REC202202020). Results will be disseminated in peer-reviewed journals, scientific and drug policy meetings and with key stakeholders via research briefs.


1 May 2010
Verified
Journal Article
Closed access
SMSinead McNamara
Sinead McNamara
SSSiobhan Stokes
Siobhan Stokes
NCN Coleman
N Coleman